Vétoquinol has announced that Zylkène, a complementary feed used to help pets cope with unpredictable situations, is now available in a 20 capsule pack.
The new packs have been designed to have more 'stand out appeal' on the shelves. Veterinary practices will now be able to display the new packs in waiting rooms and reception areas in a custom-made display unit to generate interest from pet owners and increase revenue for the practice.
Krystyna Joyce, Product Manager at Vétoquinol, said: "This has a huge benefit for the vet practice. As well as increased revenue, pet owners are much more likely to initiate a discussion about behaviour if they can see that there is a product to help their pet adjust to unusual circumstances or environmental changes."
Krystyna added: "With a number of behaviour products on the market, it can be confusing for pet owners to know which ones can be used when. We want to make it easier for pet owners: now when they come to their vets, they can see Zylkène, know what it's for, understand which strength will be right for their pet and pick it up."
As well as increasing product awareness, the packs will work alongside Vétoquinol's ongoing series of pet owner guides which offer advice on how best to help an animal deal with an unusual situation or life change.
Zylkène retail packs are available now from any veterinary wholesaler.
Petplan has issued a last call for entries to the 2009 Petplan Veterinary Awards, and announced that comedian Jason Manford, best known as team captain on Channel 4's 8 out of 10 Cats, will be the compere.
The Veterinary Awards aim to honour the special stars within the veterinary profession and nominations remain open under four different categories:
Petplan says it has already received hundreds of nominations from clients and industry professionals alike. To make sure your colleagues are considered for the accolade log onto www.petplan.co.uk/vetawards to nominate. Entries must be in by 6th February 2009.
The Petplan Veterinary Awards are to be held on Thursday 2nd April on the first evening of BSAVA.
The RCVS reports that its alternative dispute resolution (ADR) trial is now nearing completion with over two-thirds of its target number of cases either resolved or in process.
The year-long trial, which began in November 2014, aims to gather the evidence needed to develop a permanent scheme which would provide a way of adjudicating on concerns raised about a veterinary surgeon that do not meet the RCVS threshold of serious professional misconduct.
The aim of the trial, which is administered by the independent, not-for-profit Ombudsman Services, is to make determinations on around 100 cases in order to gather information about types of concern, time taken to resolve disputes, recommendations and how likely each party is to accept recommendations. As of this week some 72 cases have been referred to the trial scheme, with final decisions made in relation to 54 of these cases.
RCVS CEO Nick Stace was responsible for pushing forward the trial believing that “what is good for the consumer is good for the profession”. The College also says it brings it into line with a European Union Directive on alternative dispute resolution which, while not legally binding, specifies that regulators and other ‘competent authorities’ should have consumer redress systems in place.
Nick said: “The majority of cases are either being determined in the veterinary surgeon’s favour or finding that they need take no further action in order to resolve the dispute. Where recommendations have been made in favour of the client, the suggested remedies have generally been for a small goodwill payment to be made.
“However, the trial has not been without some frustrations so far. The fact that participation in the trial is entirely voluntary has meant that, in many cases, members of the profession have chosen not to take part.
“With this in mind, it is very important to stress the benefits of the trial to the profession – chiefly that many of the vets who chose to take part have had their actions exonerated by Ombudsman Services in a way that a concern being closed by our Professional Conduct Department does not. For clients, where a vet does have a case to answer, it gives them the chance to seek recompense without having to resort to legal action.
“Regardless of which way the decision goes in any of these cases, participating in the trial can bring these often long-standing and burdensome disputes to a close.”
The trial will continue to run until the end of October and a full report and recommendations will be presented to RCVS Council at its meeting on Thursday 5 November 2015. Full details of the trial and its parameters can be found at www.rcvs.org.uk/adr
Veterinary advice and care has, of course, always been contextual, but the term has gained greater traction due to the cost of living crisis and the Competition and Markets Authority investigation.
At Congress, there will be several "Big Issue" panel discussions on this subject, with speakers exploring how the profession can play a role in building a better understanding between vets and clients on the topic of vet fees.
On the afternoon of day two, delegates will be able to hear an update on the CMA review and what to expect from it over the next few months from Martin Coleman, Panel Chair and Panel Inquiry Chair of the CMA.
On the final day (Saturday 22nd), the Big Issues module will bring discussions from the RCVS on the latest under care guidelines, an update on Schedule 3, and a look at the future of the regulation changes.
The day will end with a panel discussion on the ethical challenges that professionals face in practice, and the impact that they can have on individuals within the practice team
Advance tickets available at: https://www.bsavacongress.com until 5th February.
Intervet has announced that its bluetongue vaccine, Bovilis® BTV8 has been granted a licence by the Veterinary Medicines Directorate (VMD). The licence, which is the first for a bluetongue vaccine in the UK, sets out dose rates and treatment regimes for the product use.
The recommended dose rates for animal over one month of age are as follows:
Sheep – 1 x 1ml, injected subcutaneously.
Cattle - 2 x 1ml, approximately three weeks apart, injected subcutaneously.
In successive years, re-vaccination should be given two weeks prior to the risk period.
Treated animals should have protective immunity three weeks after the initial course. Bovilis BTV8 should only be administered to healthy animals. Treated stock may have a slight swelling at the site of injection.
The vaccine must be stored at between 2ºC – 8ºC and, once opened, should be used within eight hours. The vaccine is available in 20ml and 50ml bottles. The licence recommends the use of multi injection vaccination systems.
Intervet will be supplying a discounted 1ml vaccination gun into the market.
The European Society of Feline Medicine (ESFM) is expanding the scope and reach of its Journal of Feline Medicine and Surgery (JFMS) in January 2009 by moving to a monthly schedule and introducing six colourful new clinical issues which will alternate with the now well-established classic issues.
JFMS, the official journal of both ESFM and of the American Association of Feline Practitioners (AAFP), has an excellent citation index and is ever-growing with record numbers of high quality papers being received. The clinical issues of JFMS will be highly visual and contain commissioned clinical review articles enhanced by case work-ups, self-assessment questions and multimedia online elements to provide practitioners with the latest author guided evidence-based information as a tool for day-to-day feline treatment.
‘As a practitioner-orientated organisation we wanted to do more for the vet in practice. So, for ESFM's 10th anniversary we are again breaking the mould by introducing six new issues a year containing well illustrated clinical reviews, aimed specifically at practice, from the best authors around the world,' said Claire Bessant Chief Executive of the ESFM and its founding organisation the Feline Advisory Bureau (FAB).
‘The aim of JFMS ‘clinical' is to turn vision into reality by delivering opinionated reviews, and some ‘outside the box' thinking, from respected clinicians to the front line of veterinary practice,' says JFMS editor Dr Andy Sparkes.
From January, members of ESFM will receive a monthly journal - six classic (the current JFMS) and six JFMS clinical issues - classic and clinical - pure and applied - the best of feline veterinary science.
If you would like a mini-sample of the new journal then contact the FAB/ESFM office Margaret@fabcats.org or go to www.fabcats.org/esfm where you can download a pdf or view it on screen.
Individual membership of ESFM is £110 pa (Euros 145) for UK and overseas. Practice membership is £170 for the UK, £190 overseas (soruE 240). ESFM members are entitled to reduced rates to ESFM congress and gain online access to JFMS papers. Full details are available at www.fabcats.org/esfm.
Boehringer Ingelheim has launched Bitesize (www.bi-bitesize.co.uk), an educational website about canine epilepsy for veterinary surgeons.
Boehringer’s Brand Manager Craig Roxburgh said: "We have teamed up with eight neurology experts working in referral centres across the UK. These experts have covered the questions most commonly encountered when managing epilepsy cases in first opinion practice, which we hope will assist vets in their epilepsy case management."
Answers to questions are delivered as short video clips of between one and three minutes, optimised for use on smartphones and tablet devices to make them available in the practice or on the move.
Craig added: "Canine epilepsy can be a complex condition to manage. We hope therefore that when cases present, Bitesize will prove a useful and handy ‘go-to’ resource for vets to access information at the time they need it."
There's a chance to win an iPad if you visit the new site before 29th February 2016.
It will compare current prescription levels with two-year retrospective data to gain an understanding of prescribing behaviour.
It will also look at the proportion of prescriptions that are Highest Priority Critically Important Antimicrobials (HPCIAs).
Individual practice data will then be given to a dedicated AMS representative at each surgery who will be responsible for sharing it with their team - to gain an understanding of their prescribing for these conditions and to review actions which can be taken at practice level.
CPD on antimicrobial stewardship will be given to all practices to encourage responsible antimicrobial usage.
The research project will then capture ongoing data - from August 2024 until July 2025 - to show changes in antimicrobial prescribing.
The research is expected to provide an opportunity to build upon ongoing veterinary antimicrobial stewardship strategies.
This could include: using diagnostics to ensure accurate diagnoses and appropriate treatment plans, informing a change in prescribing behaviour, selecting antimicrobials responsibly, educating pet owners on antimicrobial resistance and using evidence-based guidance.
The clinical research project is being run by Kezia Wareham, Doctor of Philosophy student at Bristol Veterinary School (supervised by Dr Fernando Sanchez-Vizcaino, Dr Emi Barker, Dr Nicola Rooney and Dr Irene Bueno Padilla) and Deb Komianos, Regional Clinical Lead at CVS.
Deb said: “Antimicrobial resistance is one of the top ten global health threats and the figures projected by the WHO for attributable deaths are truly startling.
"To address the development of drug-resistant pathogens requires a One Health approach.
"It is not enough to pay lip service to AMS, we need to be leading the change."
CPD Solutions have announced 3 new dentistry and oral surgery course dates, with expert tutor Alex Smithson of the Dental, Oral and Maxillofacial Referrals in Lancashire.
All courses will include extensive wet lab sessions, which will cover conditions commonly seen in practice and answer all those questions you always wanted to ask but never had the time to look up!
For details visit http://www.cpd-solutions.com/ or call 0151 328 0444 and ask for Holly.
Janssen Animal Health is advising vets to be on the look out for coccidiosis as the spring lambing season approaches: cases usually rise in March and peak in April and May.
According to the company, some reports also suggest that the incidence of coccidiosis in calves may apparently increase during the grazing months. However, vets are reporting that interpretation of laboratory tests used to confirm diagnosis, such as oocyst count, can be problematic due to the ubiquitous nature of the Eimeria parasite in the UK.
Young animals may be infected by oocysts shed by asymptomatic carriers or infected older cohort animals. Low levels of challenge can help young animals develop immunity but exposure to high oocyst numbers, particularly in combination with stress can lead to clinical and subclinical forms of the disease. Diagnosis can be problematic, particularly in subclinical cases of disease where failure to gain weight is the main presenting sign and in clinical cases the differential diagnoses include all causes of scour in young animals.
Janssen Animal Health has suggested a few indicators that may be useful in identifying cases of coccidiosis. The Vecoxan Coccidiosis Survey in 2008 and 2009 asked farmers about their experiences of coccidiosis and identified that bad weather was a major trigger particularly in lambs; while castration and weaning were also factors in calves. As the parasite life cycle is 21 days, vets should be alert to disease 2-3 weeks after a stressor event.
The company has also suggested a few guidelines to aid interpretation of laboratory results:
Janssen says Vecoxan (diclazuril) does not interfere with the development of immunity and kills all stages of the parasite in the host.
The grants are available for small-scale clinical research projects in areas of the affiliate speciality, focusing on diseases affecting companion animals.
The projects will be selected in the hope that the study results will have a rapid and positive impact on the way diseases are diagnosed, managed and treated in general practice, as well as at a specialist level.
BSAVA says applications are particularly welcome from practitioners, as well as academics or joint applications between practice and academia.
Chris Scudder, from the Small Animal Medicine Society said: “We are delighted to be able to collaborate with BSAVA PetSavers in supporting innovative research in small animal internal medicine.
"We have a shared goal of advancing the health and well-being of small animals.
"Their invaluable and generous support enables us to fund research that makes a meaningful difference for cats, dogs, and their owners.”
Applications are also open for the BSAVA PetSavers Clinical Research Project grant, where funding of up to £20,000 is available.
https://bsava.com/petsavers/apply-for-funding/clinical-research-projects/.
Here’s a gadget I’d love to get my hands on: the Zoombak advanced GPS pet locator, launched in the UK today.
The locator attaches to any dog collar, or indeed your car, husband, wife or teenager, and allows you to get a real time fix of their location by telephone, or on your computer. It costs £99.99 from pet retailers, with an additional £9.99 per month service subscription (£99.99 if paid annually upfront), which allows for an unlimited number of ‘locates’. Hot on its heels comes the Pawtrack, which will also cost £99.99 with a similar monthly subscription which allows for 1200 locates per month.
Pawtrack is being aimed at both cats and dogs, and whilst it is marginally smaller and lighter than the Zoombak, there isn’t a lot in it. Both are still probably too cumbersome for a cat, which is why Zoombak more pragmatically recommends its product for dogs over 7 kg.
Doubtless it won’t be long before they miniaturise the technology so that it’ll be the width of a nostril hair, thereby solving the problem of pet theft and loss completely. Meantime, these look like a practical and fun gadget for the owners of larger breeds that regularly go AWOL.
For more information on stocking Zoombak please contact Zoombak on 08708 033095.
A food ingredient could help prevent bacterial infections and could improve the growth of farm animals, according to new trials.The Journal of Medical Microbiology reports that Bimuno, a "second generation" galactooligosaccharide, was shown to suppress salmonella colonisation in mice and protect the gut from and reduce all clinical signs, symptoms and severity of salmonella infections.Researchers at the Veterinary Laboratories Agency (VLA) showed that feeding mice with Bimuno prior to salmonella infection rapidly reduced the impact of salmonella.In addition, over a five-day period, fewer salmonella were able to colonise in mice pre-dosed with Bimuno, compared with controls dosed with salmonella alone.Salmonella can be found in the intestines of farm animals and is transmitted to humans on meat products. Symptoms such as nausea, vomiting, diarrhoea can be observed and are most severe in the very young or very old - posing a serious public health problem.The findings are significant, given that the use of antibiotics in animal feed to help control infections has been banned since 2006, although is still commonplace in countries outside the EU.Bimuno is a powder, and could be added to all livestock feeds. Dr George Tzortzis, an author of the study from Clasado Ltd, said: "The growing evidence about this specific ingredient shows it has huge potential to protect livestock from salmonella. This is a positive development in the urgent search for antibiotic alternatives to help animals resist infection."Bimuno also has 'prebiotic' properties, which mean it is not destroyed, digested or absorbed in the stomach or small intestine. It therefore reaches the colon intact to selectively target and feed the host's immunity boosting bifidobacteria while reducing harmful bacteria."This study may have positive implications for both animal and human health, given that this bacterium can be transmitted to humans via the food chain."
Purina has launched a range of services and support materials to help veterinary professionals approach the subject of nutrition with owners.
The Gastrointestinal Support Pack includes a GI handbook, "lunch and learn" educational sessions, a diagnostic support tool (available at www.purinavets.eu/giapplication) and a toolkit containing information sheets and diagnostic advice.
The company has also announced the result of some consumer research it conducted through One Poll in 2013, which revealed that 77% of dogs have experienced some form of digestive health issue, but only 20% of owners had visited their vet to discuss it. The research also found that 80% of owners would be willing to change their pet's diet if it would improve their digestion.
Esther Rawlinson, Purina UK Veterinary Affairs Manager said: "GI upsets and associated 'accidents' can be really distressing for both owner and pet but are seemingly suffered as 'just one of those things' by many. This needn't be the case though, as a lot of GI-related conditions could be prevented or at least managed by the correct nutritional advice and a specially formulated veterinary diet. By addressing nutrition at every consultation, vets can better identify those patients who suffer regular GI disturbance but whose owners do not feel it worthy of mentioning when in the clinic. The survey results show that there is a huge opportunity for vets to improve the health of many more of their clients' dogs and this is why Purina has introduced a range of GI services and support materials. We aim to help vets to include a nutritional assessment in all of their consultations."
For more information call PURINA PetCare Team on 0800 212 161.
A study published in Current Biology has demonstrated that there are remarkable similarities in the way that dog and human brains respond to sound, and that dog brains, like those of people, are also sensitive to acoustic emotional cues.
Lead by Attila Andics, researchers from MTA-ELTE Comparative Ethology Research Group in Hungary trained 11 dogs to lay motionless in an fMRI brain scanner. This made it possible to run the same neuroimaging experiment on both dog and human participants - something that had never been done before. They captured both dogs' and humans' brain activities while the subjects listened to nearly 200 dog and human sounds, ranging from whining or crying to playful barking or laughing.
The resultant scans showed that dog and human brains include voice areas in similar locations. Not surprisingly, the voice area of dogs responds more strongly to other dogs while that of humans responds more strongly to other humans.
The researchers also noted striking similarities in the ways the dog and human brains process emotionally loaded sounds. In both species, an area near the primary auditory cortex lit up more with happy sounds than unhappy ones. Andics says the researchers were most struck by the common response to emotion across species.
There were some differences, too: in dogs, 48% of all sound-sensitive brain regions respond more strongly to sounds other than voices. That's in contrast to humans, in which only 3% of sound-sensitive brain regions show greater response to nonvocal versus vocal sounds.
The researchers say that the findings suggest that voice areas evolved at least 100 million years ago, the age of the last common ancestor of humans and dogs. It also offers new insight into humans' unique connection with our best friends in the animal kingdom and helps to explain the behavioural and neural mechanisms that made this alliance so effective for tens of thousands of years.
Andics said: "This method offers a totally new way of investigating neural processing in dogs. At last we begin to understand how our best friend is looking at us and navigating in our social environment."
Photograph: Borbala Ferenczy. Dogs at the MR Research Centre (Budapest).
The Diabetic Clinical Score is a quick, standardised scoring system to record the clinical signs of diabetes in a patient, which was designed by Royal Veterinary College Internal Medicine Specialist Stijn Niessen
The scoring system has been turned into a pet diabetes app which allows clients to record and monitor the impact of treatment.
CVS' aim is to use the recently validated tool in over 80% of patient cases to improve the treatment and control of diabetes whilst supporting the practice team to develop their skills in managing the condition.
Participating practices will use the DCS, alongside blood glucose measurements, to diagnose and monitor patients.
Veterinary nurses will refer animals coming in for six-monthly Healthy Pet Club check-ups to a vet for a possible diabetes diagnosis, whilst vets diagnosing diabetes will introduce owners and patients to the DCS to record a diabetes log, to help manage the condition.
To upskill and develop colleagues in the use of the DCS, dedicated vet and nurse training sessions have been held by the clinical leadership team, including a kick-off ‘diabetes day’ which focussed on current thinking and introduced the DCS tool.
CVS teams have also grouped together to agree a coordinated approach to managing pets with diabetes in their practice.
Supporting diabetes resources have also been drafted for practices, including new clinical guidelines, supporting paperwork and CPD.
Lara Wilson, Regional Clinical Lead at CVS said: “Diabetes is notoriously difficult to diagnose and different vets can use different approaches to managing cases.
“The Diabetic Clinical Score will help the whole team around the patient – the owner, vet and veterinary nurse – to effectively and cohesively manage their care.
It will implement joined-up thinking and help to put a standardised disease management framework in place.
“It will be fantastic to see the benefits that the Diabetic Clinical Score will bring to our patients and practices.
"I am certain that this will help contribute towards them providing some of the best diabetes clinical diagnosis and care in our profession.”
"The undersigned veterinary organisations would like to extend New Year’s greetings to all our colleagues in the languages of the EU. We would like to send a message in 2017 that says we value all our colleagues and their invaluable contribution across the UK, wherever they come from in the world.
Happy New YearBonne annéešťastný Nový rokGodt NytÅrGelukkig nieuwjaarHyvää uutta vuottaFrohes neues Jahr Kali chronya Boldog új évetFelice anno nuovoSzczesliwego nowego rokuFeliz año nuevoChestita nova godinaSretna Nova godinaMutlu YıllarHead uut aastatAthbhliain faoi mhaise daoibhLaimīgu Jauno gaduLaimingų Naujųjų metųIs-sena t-tajbaFeliz Ano NovoAn Nou FericitBliadhna Mhath ÙrSrečno novo letoGott nytt årBlwyddyn Newydd DdaUrte berri onFeliç any nouFeliz ano novo
Gudrun Ravetz, President of the British Veterinary Association, said: "My theme for my year as BVA President is the veterinary family and it has never been more important to pull together as one profession, whoever you are, and wherever you come from. We are delighted that there has been such an overwhelming response to this idea from Andrew Cobner, the President of the British Cattle Veterinary Association. Together with the RCVS, BVA has made clear to government our concerns about the working rights of our EU colleagues post-Brexit – as well as the potential impact on standards of animal health and welfare, and public health – and we will continue to do so."
VetSurgeon.org also wishes all its members a very Happy New Year, and in particular that it brings some common sense, clarity and certainty for those affected by Brexit.
A research project funded by The Horse Trust has found that various types of ocular tumours can be successfully treated with mitomycin C, a cytotoxic antibiotic isolated from a bacterium.
The research concludes that mitomycin C offers a safe and cost effective alternative to current treatment options such as surgery and radiation.
The research project was led by Fernando Malalana, while working as The Horse Trust's Clinical Scholar in Equine Internal Medicine at University of Liverpool. Fernando is now working as a Clinician Teacher in Equine Internal Medicine at the university.
Ocular tumours are more difficult to treat than tumours in other parts of the horse's body due to the risk of damaging the eye. In the study, Malalana investigated the use of mitomycin C in treating ocular squamous cell carcinoma, the most common ocular tumour in horses, and occular sarcoids, skin tumors that frequently affect the eyelids .
Mitomycin C is an antibiotic isolated from a bacterium, Streptomyces caespitosus. It is known to have cytotoxic effects and has been used to treat tumours in horses before, but only in combination with surgery.
Currently, the main method of treating ocular squamous cell carcinoma is by removing the tumour surgically or with radiation. Both treatments are costly and have a number of associated risks. There is also the risk of damage or scarring to the eye.
Fourteen horses with ocular squamous cell carcinoma, three of which were affected bilaterally, were included in the study. Mitomycin C was applied to the conjunctival sac of the affected eye; in some of the cases the treatment was combined with surgery. Malalana found that of the 8 eyes treated with mitomycin C alone, clinical resolution occurred in 6 cases. Of the 9 eyes treated with both surgery and mitomycin C, clinical resolution occurred in 7 cases.
Mitomycin C was also used to treat various types of sarcoids found in the eye. Currently, the most effective treatment for occular sarcoids is radioactive wire. However, radioactive wire treatment is not ideal as it is expensive, only offered in two locations in the UK, and has potential health risks to the vet applying the wire due to exposure to radioactivity.
Six horses and two donkeys with occular sarcoids, including one horse that was affected bilaterally, were treated with mitomycin C, which was injected directly into the tumour. Malalana found that of the nine nodular and fibroplastic occular sarcoids treated with the antibiotic, all were completely cleared. However, the vets did not have good results with verrucous sarcoids.
Malalana said: "The results of this research should offer hope to the owners of horses that have eye tumours. We have already been contacted by vets from across Europe to find out more information about this treatment and hope that it will be offered to more horses with occular tumours in the future".
Vets at the University of Liverpool are now testing the use of mitomycin C on other tumours that are difficult to treat surgically, including melanomas near the horse's anus. So far, two cases have been treated, but it is too early to tell whether treatment has been successful.
Malalana's research has been submitted to Veterinary Ophthalmology journal.
Merial Animal Health, manufacturer of Previcox, has launched a new campaign in small animal practices across the UK to continue to spread the message of 'total joint health'.
As part of the campaign, Merial has produced 'The A-Z of Canine Mobility' - a series of short articles and bite-sized information which can be disseminated to clients, helping to educate dog owners about canine osteoarthritis and the treatment options available.
Previcox Brand Manager Kathryn England said: "We are providing regularly updated articles and information to interested practices in a form that is easily pasted into a newsletter, eshot or fixed to a waiting room wall so that they can communicate with their clients quickly and easily. It's essentially free information to encourage owners to bring their dogs in for a joint check up."
Merial says the message about the importance of joint health and osteoarthritis is not well understood by pet owners, as demonstrated by a recent survey1 which found that only 53% of the owners of old dogs considered reduced willingness to exercise as serious enough to require veterinary attention.
Merial's Technical Manager, Kevin Whelan said: "The results highlight the fact that owners of older pets, even those who would be considered as responsible pet owners, do not consider signs such as unwillingness to exercise or hind leg stiffness to be particularly important. It's therefore important to educate and engage pet owners on this topic to encourage them to seek advice from their vet"
To sign up for regular free updates contact your Merial Territory Manager or call or call 0870 6000 123.
Reference
1. (Davies, 2011)
Animus4Vets has launched a new complete series of training CDs. The new series of 4 CDs is entitled Sales and Merchandising and covers aspects such as consulting room sales, waiting room sales and educational displays.
Animus4Vets says the new CDs have been designed in a similar format as their first Client Care series and aim to enable veterinary practices to run their own in-house training.
For more information go to http://www.animus4vets.com/ and follow the CD training links or phone 01449 775330.
New and recent graduates and recently qualified vets have the opportunity to attend a CPD graduate symposium specifically designed to provide practical surgical and management advice and solutions for those embarking on their professional careers.
ProStart course director Colin Whiting BVSc CertSAS MRCVS explained: "We're aiming to fast-track new graduates by sharing experience and helping them through that tricky first year in practice. However, whilst the course has a total of 11 hours CPD, it also has a packed fun and social element including zip wire and surf lessons."
Sponsored by Merial Animal Health, the inaugural ProStart CPD graduate symposium is to be held at Lusty Glaze beach adventure and lecture centre, Newquay, Cornwall, Friday 10th to Sunday 12th October 2008.
Mr Whiting said: "The event includes a full-on itinerary of lectures and workshops covering aspects of small animal practice including, practice economics, consultation skills, surgical guides for neutering, maximising therapeutic opportunities, and client and staff interactions - with tips from a head nurse. It's also a great opportunity to network with other new graduates.
"The workshops are run by vets experienced in mentoring new graduates in practice, plus full board & lodging and a vibrant social programme including adventure Zip wire, Surf lesson, and entertainment."
For Merial's Mark Riggs the symposium will help graduates understand the realities of practice environment more quickly. He said: "This course is a neat combination of practical and business skills. Not only will graduates have the chance to sharpen their neutering techniques but advice will be on hand relating to practice finances, client handling and staff management. Delegates will be encouraged to contribute within workshops tackling thorny issues from general practice, before it's wetsuits on and a surf lesson."
Mr Whiting, a referral surgeon and clinical director based at Penmellyn Vet Group in Cornwall has publications and CPD presentations which focus on surgical and practice management topics, and include Surgical Mentoring of Junior Colleagues for In Practice.
"We have a very experienced lecture team, members of which have worked extensively supporting graduates and junior colleagues. Bearing in mind that CPD has to be affordable for practice owners, thanks to our sponsors, Merial, we're able to provide an entire weekend course, including accommodation, for £240+VAT. The venue's proximity to Newquay airport provides easy accessibility for delegates nation-wide and is a fantastic venue for adventure challenges, surfing and various beach activities."
Other members of the ProStart team include Ian Stroud BVSc MRCVS a Medivet partner and new graduate supervisor, and Gareth Cross BVSc, MRCVS who recently lectured to BSAVA congress. Their focus will be promoting safe clinical excellence; illustrating the finances behind a small animal practice; and how graduates can add to a practice in these areas.
If you would like more information on the course or would like to book a place please contact Beverley Archer; beverly.archer@merial.com, or contact your local Merial Territory Manager.
Supreme Petfoods has published protocols for the veterinary care of rabbits, guinea pigs and other small furries on its website: www.supremepetfoods.com.
The new infomation resource includes nursing plans and protocols for specific conditions, hospitalisation records, instructions on how to administer fluid therapy, take a blood sample, conduct a behavioural assessment and best practice manual handling.
The materials have been produced by Wendy Bament, exotic animal veterinary nurse at the Royal (Dick) School of Veterinary Studies in Edinburgh. Following workshops at the London Vet Show last year and feedback from the delegates, Wendy has transcribed some of the processes and protocols developed by the exotics team at Edinburgh for dissemination to veterinary practices across the UK.
Claire Hamblion, Marketing Manager at Supreme said: "I can't tell you how pleased we are to be involved in distributing these documents to the profession. The feedback from our live workshops really demonstrated the demand for material that would provide a framework for best practice care of small furries and now, thanks to Wendy and the team at Edinburgh, it's available to everybody. We genuinely believe that in many practices these protocols could change the approach to small furries forever."
Each event is designed to help attendees with:
Each attendee will be given a complimentary annual Veterinary Osteoarthritis Alliance (VOA) membership.
Kai Crawshaw, Animalcare Brand Manager said: "We had excellent feedback from our first workshops, so we’re pleased to be able to reach veterinary practices in more locations around the UK.
"We also have plans to run more across the rest of the year.
"We hope that these events will lead to veterinary staff becoming more confident in dealing with OA in dogs and helping owners understand the options open to them."
All events start at 7:30pm (arrival from 7pm) and will finish approximately at 9:30pm.
Hot food and drinks will be provided.
https://www.animalcare.co.uk/oa-workshops